Related Experiment Video

Updated: May 14, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines

Jinyu Xiang1, Wensheng Qiu, Xingang Wang

  • 1Department of Oncology, The Affiliated Hospital of the Medical College, Qingdao University, Qingdao 266003, PR China.

Oncology Reports
|January 29, 2013
PubMed

Insights

Overexpressing ErbB-2 in breast cancer is linked to TACC1. Silencing ErbB-2 increases TACC1 and enhances docetaxel sensitivity in breast cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • ErbB-2 overexpression is common in breast cancer, contributing to carcinoma formation.
  • Dysregulation of transforming acidic coiled-coil 1 (TACC1) and ErbB-2 is implicated in breast cancer development and progression.
  • The interaction between ErbB-2 and TACC1 in breast cancer remains unclear.

Purpose of the Study:

  • To investigate the molecular relationship between ErbB-2 and TACC1 in breast cancer.
  • To determine the effect of ErbB-2 silencing on TACC1 expression.
  • To assess the impact of ErbB-2 inhibition on breast cancer cell sensitivity to docetaxel.

Main Methods:

  • Utilized lentiviral-mediated ErbB2-specific shRNA to infect BT474 cells.
  • Quantified ErbB-2 and TACC1 expression using real-time PCR and western blotting.
  • Assessed cell proliferation and drug sensitivity via CCK-8 assay.

Main Results:

  • ErbB-2 silencing significantly reduced ErbB-2 mRNA and protein levels in BT474 cells.
  • TACC1 expression, at both mRNA and protein levels, was significantly upregulated following ErbB-2 silencing.
  • Inhibition of ErbB-2 expression enhanced the sensitivity of BT474 cells to docetaxel treatment.

Conclusions:

  • Demonstrated a significant upregulation of TACC1 expression upon ErbB-2 silencing in breast cancer cells.
  • Provided evidence for a molecular and biological relationship between ErbB-2 and TACC1 in breast cancer.
  • Established that inhibiting ErbB-2 expression can increase breast cancer cell sensitivity to docetaxel, suggesting therapeutic potential.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...